scispace - formally typeset
Open AccessJournal ArticleDOI

Identification of redox/repair protein Ref-1 as a potent activator of p53.

TLDR
It is found that HeLa nuclear extracts can stimulate DNA binding by latent p53 and it is determined that Ref-1 can stimulate p53 transactivation in vivo, the first example of a noncovalent protein modifier of p53 function identified in cells.
Abstract
p53 can be isolated from cells in a form that is inert for binding to DNA but that can be stimulated dramatically by phosphorylation, antibody binding, or short single strands of DNA. This suggests that upon genotoxic stress, cells can convert latent p53 to one that is active for DNA binding. Surprisingly, we observed that latent p53 is as effective in activating transcription in vitro as is active p53. We found that HeLa nuclear extracts can stimulate DNA binding by latent p53 and have purified from them a p53-stimulating protein that we have determined to be the product of the Ref-1 gene. Interestingly, Ref-1 is a dual function protein that can both regulate the redox state of a number of proteins and function as a DNA repair (A/P) endonuclease. We observed that oxidized forms of full-length and carboxy-terminally truncated p53 (p53 delta30), which are inactive for DNA binding, are both stimulated by the Ref-1 protein. However, in the presence of reducing agent, Ref-1 is an extremely potent stimulator of full-length p53 but not p53 delta30. These and additional data indicate that Ref-1 protein stimulates p53 by both redox-dependent and -independent means and imply a key role for it in p53 regulation. Importantly, we have also determined that Ref-1 can stimulate p53 transactivation in vivo. This is the first example of a noncovalent protein modifier of p53 function identified in cells.

read more

Citations
More filters
Journal ArticleDOI

The p53 pathway

TL;DR: Progress in the analysis of signalling to p53 including phosphorylation cascades, and interactions with proteins such as mdm2 and ARF are highlighted, and the plethora of protein–protein interactions is discussed, as are the strategies for defining downstream targets of p53.
Journal ArticleDOI

The complexity of p53 modulation: emerging patterns from divergent signals

TL;DR: The activity of p53 can increase in normal tissues when undergoing pathophysiological changes that result in oxidative or redox stress, such as ischemia and reperfusion injury of the brain, heart, and other tissues.
Book ChapterDOI

p53 and human cancer: the first ten thousand mutations.

TL;DR: The chapter describes a three-step model of pS3 activation by stress signals and concludes with the potential clinical applications of the detection of p53 mutations in human tissues.
Journal ArticleDOI

Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2

TL;DR: Overexpression of p19(ARF) in wild type or ARF-null mouse embryo fibroblasts increases the half-life of p53 from 15 to approximately 75 min, correlating with an increased p53-dependent transcriptional response and growth arrest.
Journal ArticleDOI

An integrated view of oxidative stress in aging: basic mechanisms, functional effects, and pathological considerations

TL;DR: Mechanisms of in vivo ROS generation are described, the potential impact of ROS and oxidative damage on cellular function is examined, and how these responses change with aging in physiologically relevant situations are evaluated.
References
More filters
Journal ArticleDOI

p53: puzzle and paradigm.

TL;DR: Some of the key developments leading to the current state of knowledge in p53 research are presented and how they either shed light on or add to the complexities of p53 are discussed.
Journal ArticleDOI

Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours

TL;DR: It is proposed that hypoxia provides a physiological selective pressure in tumours for the expansion of variants that have lost their apoptotic potential, and in particular for cells acquiring p53mutations.
Journal ArticleDOI

Redox regulation of fos and jun DNA-binding activity in vitro

TL;DR: DNA binding of the Fos-Jun heterodimer was modulated by reduction-oxidation of a single conserved cysteine residue in the DNA-binding domains of the two proteins, suggesting that transcriptional activity mediated by AP-1 binding factors may be regulated by a redox mechanism.
Journal ArticleDOI

Regulation of the specific DNA binding function of p53

TL;DR: It is shown that p53 DNA binding is cryptic but can be activated by cellular factors acting on a C-terminal regulatory domain of p53, which may be critical in regulation of its ability to arrest cell growth and thus its tumor suppressor function.
Related Papers (5)